MediSpend recently acquired Real Life Sciences (RLS), the leading provider of clinical data and documents anonymization and redaction for the life sciences industry. Their platform, RLS Protect, is the industry leading solution which helps trial sponsors prepare required regulatory disclosure submissions and clinical data for sharing purposes.
Listen as Elliot Zimmerman, CEO of RLS, shares […]
In September 2024, the Department of Justice (DOJ) released an updated version of its Evaluation of Corporate Compliance Programs (ECCP) Guidance. The ECCP serves as a framework for DOJ prosecutors to evaluate a company’s compliance program when considering the appropriate enforcement actions. While updates were made across multiple topics, the most notable changes focus on […]
Pharmaceutical and medical device companies operate in a highly regulated and competitive landscape where efficient, compliant event management is essential. From medical congresses and training workshops to key opinion leader (KOL) meetings, these events shape industry relationships and drive innovation. As companies evaluate event management systems, they look for solutions that streamline processes, deliver educational […]
In September 2024, the Department of Justice (DOJ) released an updated version of its Evaluation of Corporate Compliance Programs (ECCP) Guidance. The ECCP serves as a framework for DOJ prosecutors to evaluate a company’s compliance program when considering the appropriate enforcement actions. While updates were made across multiple topics, the most notable changes focus on […]
Portsmouth, NH – January 27, 2025 — MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, announces its acquisition of Real Life Sciences (RLS), a leader in advanced anonymization solutions for clinical trial and other data. MediSpend’s second acquisition in less than a year reinforces its commitment to expanding its presence […]
In the competitive landscape of life sciences, building and nurturing strong relationships with key opinion leaders (KOLs) is crucial for success. These influential experts are at the forefront of medical innovation, driving drug advocacy and shaping the future of healthcare. Managing these relationships effectively, while ensuring full compliance, can be a complex challenge. MediSpend’s KOL […]
Listen as our experts discuss the importance of identifying and partnering with the right KOLs.
Key topics include:
In today’s life sciences organizations, the importance of effectively auditing and monitoring interactions with healthcare professionals (HCPs) cannot be overstated. Data analytics is a powerful tool which enables organizations to gain insights and ensure compliance while optimizing engagement strategies.
In this webinar, MediSpend experts highlight the significance of data analytics in auditing and monitoring interactions with […]
The elements of an effective compliance program provide a framework for life sciences companies to ensure their program is comprehensive and practicable. These same elements can be tailored to create an effective compliance training program for transparency reporting. By applying this framework to your transparency training, companies can enhance compliance with transparency reporting obligations, ensuring […]
In recent years, anti-bribery and anti-corruption enforcement penalties have been increasing in number and size, and recent actions illustrate that third parties continue to be a concern. For life sciences companies, managing these risks is crucial to complying with laws such as the US Anti-Kickback Statute, the Foreign Corrupt Practices Act and the UK Bribery […]
